Clinical Trials Directory

Trials / Terminated

TerminatedNCT00805779

Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
EMKinetics, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the initial safety and clinical feasibility of neuromodulation therapy in treating patients with documented overactive bladder. The specific aim is improved urinary frequency and urgency after 12 weeks of treatment

Detailed description

Twenty to Forty patients with documented overactive bladder will receive 30 minutes of treatment one day a week for 12 weeks. Treatment will consist of stimulating the posterior tibial nerve in the area of the ankle with a pulsed electromagnetic field. Study treatments will be administered by a commercially available MagPro R30, with a cooled figure eight coil, and a surface electrode placed over the afferent pathway of the sacral nerve. The specific aim is improved urinary frequency and urgency after 12 weeks of treatment. Secondary goals. * To estimate the extent to which the device will decrease the number of episodes of involuntary urine loss due to frequency/urgency in comparison to historical controls. * To evaluate the potential of the device for improving patient quality of life as measured by a clinically validated scale, such as the Incontinence Quality of Life Instrument (I-QOL) or equivalent * To periodically employ a micturition diary to record variables such as day/night urgency/frequency episodes, number of voids per day, severity of leaks, number of absorbent products used per day, etc.

Conditions

Interventions

TypeNameDescription
DEVICEMagPro R30Study treatments will be administered by a commercially available MagPro R30, with a cooled figure eight coil. The figure eight coil is placed directly over the posterior tibial nerve and the MagPro R30 will be activated. The coil will stimulate the posterior tibial nerve at 20 pulses per second for a 30 minute session.

Timeline

Start date
2008-12-01
Primary completion
2009-12-01
Completion
2010-04-01
First posted
2008-12-10
Last updated
2011-06-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00805779. Inclusion in this directory is not an endorsement.